This agreement will strengthen the balance sheet and streamline resources to advance a robust pipeline of first-in-class and best-in-class drug candidates and expand the product portfolio through...
These findings are expected to advance research in endothelial activation and angiogenesis and facilitate selective epigenomic drug discovery for age-related vascular diseases. Professor Takashi...
A new collaboration between data science and analytics leader, Excelra, and artificial intelligence pioneer X-Chem will accelerate preclinical drug discovery and aid scientists to find new drug...
COVID-19 has highlighted the cracks in our current healthcare systems, protocols, and policies. How can we address these vulnerabilities and what more can we look forward to in the years to come? The...
This novel framework provides more accurate and robust drug-target interaction predictions than conventional methods, potentially bringing down the cost and time spent in drug development. In drug...
The partnership will help train XtalPi's models to accurately predict efficacy and safety parameters, increasing the success rate of drug design. Excelra, a leading global Data Analytics...
Researchers from the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) have developed self-organising heart organoids, known as cardioids, that recapitulates a heart...
Drug discovery is the first step towards the development of new therapeutics. From the first screening to the launch of preclinical testing the process is long, coupled with high cost and...
In the heyday of artificial intelligence (AI), many were afraid to lose their jobs to something initially designed to make lives better. Amid the COVID-19 outbreak, AI has come to their rescue, and...
Drug discovery is slow, expensive and cursed with high failure rates. As the COVID-19 outbreak screams for a cure to stop it, Deargen Inc. shows the world how to exploit artificial intelligence (AI)...
AUM Biosciences and Cyclica, Inc to partner under Project Nexus to propel drug discovery for cancer. Singapore-based clinical-stage biotechnology company, AUM Biosciences focuses on early stage...
A microvessel-on-a-chip, jointly developed and optimized by Philip Morris International (PMI) and organ-on-a-chip specialists MIMETAS (Leiden, The Netherlands), used to detect early onset of...
